Home / Resource Library / Brentuximab Vedotin and Nivolumab for Untreated Patients with Hodgkin Lymphoma: Long-term ResultsBrentuximab Vedotin and Nivolumab for Untreated Patients with Hodgkin Lymphoma: Long-term Results